Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunotherapy in genitourinary neoplasia.

The Urologic Clinics of North America

|November 1, 1984

Summary

The immune system

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors.

Urologic oncology·2011

Same author

Standardization in pathologic assessment of transitional cell cancer of the bladder.

Urologic oncology·2011

Same author

Translational research in urology: From the laboratory to the clinic.

Urologic oncology·2011

Same author

Risk factors in clonal development from superficial to invasive bladder cancer.

Cancer surveys·2004

Same author

Putative protein markers in the sera of men with prostatic neoplasms.

BJU international·2003

Same author

Association between serum triiodothyronine (t3) level and risk of disease recurrence in men with localized prostate cancer.

Prostate cancer and prostatic diseases·2002

Area of Science:

Immunology and Oncology

Background:

The role of immune response in cancer defense is unclear.
Cancer therapy utilizing immune responses is underdeveloped.
Aging-related immune decline (immunosenescence) complicates cancer treatment.

Purpose of the Study:

To explore the challenges in leveraging immune responses for cancer therapy.
To examine the impact of immunosenescence on cancer treatment efficacy.

Main Methods:

Review of existing research on immune response and neoplasia.
Analysis of therapeutic strategies for genitourinary cancers.

Main Results:

Complex immune-tumor interactions hinder therapeutic development.
Tumor cell heterogeneity presents a significant challenge.
Immunosenescence further limits the effectiveness of immunotherapies.

Conclusions:

Future cancer therapy efforts must address immune system complexities.
Targeting genitourinary neoplasia requires innovative approaches to immune modulation.
Overcoming challenges in cancer immunology is crucial for therapeutic advancement.

Related Experiment Videos